Information  X 
Enter a valid email address

Motif Bio PLC Ord 1P (MTFB)

Date Time Source Announcement
25 Mar 2019 9:49 am
RNS
Proposed Equity Fundraise
20 Mar 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Motif Bio Granted Meeting with U.S. FDA
18 Mar 2019 7:00 am
RNS
Appointment of Bruce Williams as Interim Chairman
15 Mar 2019 7:01 am
RNS
Holding(s) in Company
  7:01 am
RNS
Holding(s) in Company
07 Mar 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
19 Feb 2019 7:00 am
RNS
Conference Call and Webcast
18 Feb 2019 7:00 am
RNS
Amendment Agreement with Hercules Capital
15 Feb 2019 4:28 pm
RNS
Holding(s) in Company
  4:28 pm
RNS
Holding(s) in Company
  4:26 pm
RNS
Holding(s) in Company
14 Feb 2019 7:00 am
RNS
Complete Response Letter from the FDA
05 Feb 2019 7:00 am
RNS
Exercise of Warrants
23 Jan 2019 4:31 pm
RNS
Exercise of Warrants
01 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
31 Oct 2018 7:00 am
RNS
Jefferies London Healthcare Conference
30 Oct 2018 4:35 pm
RNS
Price Monitoring Extension
16 Oct 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
03 Oct 2018 8:01 am
RNS
Motif Bio Presents New Iclaprim Data at IDWeek
28 Sep 2018 7:01 am
RNS
Motif Bio Notes Statement from Amphion Innovations
25 Sep 2018 7:00 am
RNS
Half-year Report
20 Sep 2018 7:00 am
RNS
Upcoming Scientific Conferences
05 Sep 2018 7:00 am
RNS
Iclaprim Data presented at ESCMID/ASM Conference
29 Aug 2018 4:35 pm
RNS
Price Monitoring Extension
21 Aug 2018 7:15 am
RNS
Motif Bio notes statement from Amphion Innovations
  7:15 am
RNS
Motif Bio notes statement from Amphion Innovations
17 Aug 2018 7:00 am
RNS
Iclaprim Data at ESCMID/ASM Conference
14 Aug 2018 4:49 pm
RNS
Holding(s) in Company
  4:49 pm
RNS
Holding(s) in Company
  4:48 pm
RNS
Holding(s) in Company
  4:48 pm
RNS
Holding(s) in Company
  7:00 am
RNS
FDA Acceptance of New Drug Application
09 Aug 2018 7:00 am
RNS
Investor Events in August and September
08 Aug 2018 7:00 am
RNS
Notice of Allowance for Two U.S. Iclaprim Patents
02 Aug 2018 4:35 pm
RNS
Price Monitoring Extension
03 Jul 2018 4:48 pm
RNS
Holding(s) in Company
  4:48 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Directorate Change
26 Jun 2018 11:57 am
RNS
Exercise of Stock Options
19 Jun 2018 1:58 pm
RNS
Result of AGM
14 Jun 2018 7:00 am
RNS
Motif Bio Submits NDA for Iclaprim
11 Jun 2018 11:41 am
RNS
Holding(s) in Company
  11:41 am
RNS
Holding(s) in Company
  7:00 am
RNS
Motif Bio present New Iclaprim Data at ASM Microbe
08 Jun 2018 5:08 pm
RNS
Holding(s) in Company
  5:08 pm
RNS
Holding(s) in Company
31 May 2018 7:00 am
RNS
Jefferies Global Healthcare Conference
25 May 2018 4:04 pm
RNS
Holding(s) in Company
  4:04 pm
RNS
Holding(s) in Company
24 May 2018 4:39 pm
RNS
Holding(s) in Company
  4:39 pm
RNS
Holding(s) in Company
23 May 2018 5:42 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Motif Bio notes statement from Amphion Innovations
  7:00 am
RNS
Motif Bio notes statement from Amphion Innovations
17 May 2018 2:24 pm
RNS
Result of Placing
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t